ATARAX Trademark

Trademark Overview

On Monday, May 15, 2023, a trademark application was filed for ATARAX with the United States Patent and Trademark Office. The USPTO has given the ATARAX trademark a serial number of 97936545. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, October 30, 2024. This trademark is owned by Casper Pharma, LLC. The ATARAX trademark is filed in the Pharmaceutical Products category with the following description:

Prescription medication for symptomatic relief of anxiety and tension and for the management of pruritus due to allergic conditions
atarax

General Information

Serial Number97936545
Word MarkATARAX
Filing DateMonday, May 15, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, October 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2024

Trademark Statements

Goods and ServicesPrescription medication for symptomatic relief of anxiety and tension and for the management of pruritus due to allergic conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCasper Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEast Brunswick, NJ 08816
Party NameCasper Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEast Brunswick, NJ 08816

Trademark Events

Event DateEvent Description
Friday, August 11, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 11, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 11, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 11, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 11, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, January 22, 2024ASSIGNED TO EXAMINER
Wednesday, January 24, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 24, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, January 24, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 24, 2024EXAMINER'S AMENDMENT ENTERED
Friday, January 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 30, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 30, 2024SOU EXTENSION 1 FILED
Wednesday, October 30, 2024SOU EXTENSION 1 GRANTED

Related Keywords

atarax management pruritus allergic conditions tension anxiety medication symptomatic relief prescription